WO2011052482A1 - Bactérie productrice d'alcool isopropylique et procédé de production d'alcool isopropylique - Google Patents

Bactérie productrice d'alcool isopropylique et procédé de production d'alcool isopropylique Download PDF

Info

Publication number
WO2011052482A1
WO2011052482A1 PCT/JP2010/068631 JP2010068631W WO2011052482A1 WO 2011052482 A1 WO2011052482 A1 WO 2011052482A1 JP 2010068631 W JP2010068631 W JP 2010068631W WO 2011052482 A1 WO2011052482 A1 WO 2011052482A1
Authority
WO
WIPO (PCT)
Prior art keywords
isopropyl alcohol
escherichia coli
gene
strain
activity
Prior art date
Application number
PCT/JP2010/068631
Other languages
English (en)
Japanese (ja)
Inventor
智量 白井
敬 森重
均 高橋
仰 天野
淳一郎 平野
佳子 松本
のぞみ 竹林
光史 和田
Original Assignee
三井化学株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 三井化学株式会社 filed Critical 三井化学株式会社
Priority to JP2011538386A priority Critical patent/JPWO2011052482A1/ja
Publication of WO2011052482A1 publication Critical patent/WO2011052482A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/22—Processes using, or culture media containing, cellulose or hydrolysates thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)

Definitions

  • the present invention relates to an isopropyl alcohol-producing bacterium and an isopropyl alcohol production method using the bacterium.
  • Propylene is an important basic raw material for synthetic resins such as polypropylene and petrochemical products, and is widely used in automotive bumpers, food containers, films, medical equipment, and so on.
  • Isopropyl alcohol produced from plant-derived materials is promising as a carbon-neutral propylene material because it can be converted to propylene through a dehydration step.
  • it is obliged to reduce carbon dioxide emissions by 5% compared to 1990 levels throughout the developed countries between 2008 and 2012 according to the Kyoto Protocol.
  • Carbon neutral propylene is extremely important for the global environment due to its versatility. It is.
  • JP 2007-510411 A encodes glucose-6-phosphate isomerase (phosphoglucose isomerase), which is a main enzyme of glycolysis, in addition to genes encoding quinone oxidoreductase and soluble transhydrogenase.
  • JP 2007-510411 A encodes glucose-6-phosphate isomerase (phosphoglucose isomerase), which is a main enzyme of glycolysis, in addition to genes encoding quinone oxidoreductase and soluble transhydrogenase.
  • Bacteria that have the gene deleted to produce ethyl-3-hydroxybutyrate have been disclosed.
  • 2003-520583 discloses a method for producing a polyol by comparing a yeast in which the activity of glucose-6-phosphate isomerase is reduced with a yeast in which the enzyme gene is completely deleted. It is described that maintaining the activity of glucose-6-phosphate isomerase is necessary for improving productivity, and that the effect of improving productivity is lost when enzyme activity is deleted. Furthermore, it has been reported that when the glucose-6-phosphate isomerase gene of DOI-producing Escherichia coli into which 2-deoxy-siro-inosose (DOI) -producing enzyme is introduced is disrupted, the yield of DOI is improved (for example, Journal). of Biotechnology., 129, pp. 502-509, (2007)).
  • DOI 2-deoxy-siro-inosose
  • An object of the present invention is to provide an isopropyl alcohol-producing Escherichia coli and an isopropyl alcohol production method useful for producing isopropyl alcohol with high purity.
  • the present invention has been made in view of the above situation, and the isopropyl alcohol-producing Escherichia coli and the isopropyl alcohol production method of the present invention are as follows.
  • Each enzyme derived from at least one selected from the group consisting of Clostridium bacteria, Bacillus bacteria, and Escherichia bacteria, wherein the acetoacetate decarboxylase activity, isopropyl alcohol dehydrogenase activity, CoA transferase activity, and thiolase activity are each The isopropyl alcohol-producing Escherichia coli according to [3], which is obtained by introduction of a gene to be encoded.
  • the acetoacetate decarboxylase activity and isopropyl alcohol dehydrogenase activity are obtained by introduction of genes encoding each enzyme derived from Clostridium bacteria, and the CoA transferase activity and thiolase activity are derived from Escherichia bacteria.
  • the acetoacetate decarboxylase activity is obtained by introduction of a gene encoding an enzyme derived from Clostridium acetobutylicum
  • the isopropyl alcohol dehydrogenase activity is obtained by introduction of a gene encoding an enzyme derived from Clostridium beigerinki.
  • the isopropyl alcohol-producing Escherichia coli according to any one of [1] to [6], further comprising at least a sucrose hydrolase gene in a sucrose non-PTS gene group.
  • a method for producing isopropyl alcohol comprising producing isopropyl alcohol from a plant-derived material using the isopropyl alcohol-producing Escherichia coli according to [1] to [7].
  • the isopropyl alcohol-producing Escherichia coli of the present invention is an isopropyl alcohol-producing Escherichia coli having inactivated glucose-6-phosphate isomerase activity and having an isopropyl alcohol production system.
  • isopropyl alcohol-producing Escherichia coli of the present invention since the activity of glucose-6-phosphate isomerase inherent in E. coli is inactivated, the production of acetone as a by-product is reduced and isopropyl alcohol is produced with high purity. be able to.
  • the present invention inactivates glucose-6-phosphate isomerase activity, which is one of the main enzymes of glucose decomposition (glycolysis), among metabolic pathways that decompose glucose into isopropyl alcohol. It has been found that the purity of the product isopropyl alcohol of the E. coli is improved. Glucose-6-phosphate isomerase is a major enzyme in glycolysis, and the knowledge that inactivation of the gene encoding the enzyme is involved in the productivity of isopropyl alcohol has never been can not see. Furthermore, there is no knowledge that clarifies the effect of inactivating glucose-6-phosphate isomerase activity in reducing the amount of acetone, which is a by-product, in the production of isopropyl alcohol. Therefore, it was completely unexpected that the inactivation of glucose-6-phosphate isomerase activity improved the purity of isopropyl alcohol in the product.
  • the “inactivation” in the present invention refers to a state where the activity of the enzyme measured by any existing measurement system is below the detection limit.
  • the term “by genetic recombination” means that a change in the base sequence is caused by the insertion of another DNA into the base sequence of the native gene, or the substitution, deletion or combination of a part of the gene. Anything may be included, for example, it may be obtained as a result of mutation.
  • “Activation” or “enhancement” of “activity” or “ability” in the present invention refers to the introduction of a gene encoding an enzyme from outside the host bacterial cell into the bacterial body, It includes those in which the expression of the enzyme gene is enhanced by enhancing the promoter activity of the enzyme gene possessed or by replacing it with another promoter.
  • the “host” means the E. coli that becomes the isopropyl alcohol-producing E. coli of the present invention as a result of introduction of one or more genes from outside the cell. The present invention will be described below.
  • the glucose-6-phosphate isomerase in the present invention is classified into enzyme number 5.3.1.9 according to the report of the International Biochemical Union (IUB) enzyme committee, and D-glucose-6 -A generic term for enzymes that catalyze the reaction of producing D-fructose-6-phosphate from phosphate.
  • IUB International Biochemical Union
  • E. coli in which the enzyme activity is inactivated refers to a bacterium whose native activity is impaired by some method from outside the microbial cell to the microbial cell, in the same manner as the bacterium imparted with the above activity.
  • These bacteria can be produced, for example, by destroying genes encoding the enzymes and proteins (gene disruption).
  • gene disruption refers to the introduction of a mutation in the base sequence of a gene, the insertion of another DNA, or the deletion of a certain part of a gene so that the function of the gene cannot be exhibited. Show.
  • gene disruption for example, the gene cannot be transcribed into mRNA and the structural gene is not translated, or the transcribed mRNA is incomplete, resulting in a mutation or deletion in the translated structural protein amino acid sequence. It becomes impossible to demonstrate the function of.
  • the gene-disrupted strain can be produced by any method as long as a disrupted strain that does not express the enzyme or protein is obtained.
  • Various methods of gene disruption have been reported (natural breeding, addition of mutagen, UV irradiation, irradiation, random mutation, transposon, site-specific gene disruption), but only certain genes can be disrupted Thus, gene disruption by homologous recombination is preferred. Methods by homologous recombination are described in J. Bacteriol., 161, 1219-1221 (1985), J. Bacteriol., 177, 1511-1519 (1995) and Proc. Natl. Acad. Sci. USA, 97, 6640-6645 ( 2000) and can be easily implemented by those in the same industry by using these methods and their applications.
  • the isopropyl alcohol-producing Escherichia coli in the present invention is an Escherichia coli equipped with an isopropyl alcohol production system and refers to an Escherichia coli having an isopropyl alcohol production ability introduced or modified by genetic recombination.
  • Such an isopropyl alcohol production system may be any system as long as the target Escherichia coli produces isopropyl alcohol.
  • the provision of enzyme activity involved in the production of isopropyl alcohol can be mentioned.
  • the isopropyl alcohol-producing Escherichia coli according to the present invention is more preferably provided with four types of enzyme activities including acetoacetate decarboxylase activity, isopropyl alcohol dehydrogenase activity, CoA transferase activity, and thiolase activity.
  • the acetoacetate decarboxylase in the present invention is classified into enzyme number 4.1.1.4 based on the report of the International Biochemical Union (I.U.B.) Enzyme Committee, and produces acetone from acetoacetate.
  • the generic name of the enzyme that catalyzes Examples thereof include those derived from genus Bacillus such as Clostridium acetobutylicum and Clostridium beijerinckii, and Bacillus polymyxa.
  • the gene of acetoacetate decarboxylase introduced into the host bacterium of the present invention is synthesized based on DNA having the base sequence of the gene encoding acetoacetate decarboxylase obtained from each of the above-mentioned organisms or a known base sequence thereof.
  • the synthesized synthetic DNA sequence can be used.
  • Preferable examples include those derived from Clostridium bacteria or Bacillus bacteria, and examples thereof include DNA having a nucleotide sequence of a gene derived from Clostridium acetobutylicum or Bacillus polymixa. Particularly preferred is DNA having a base sequence of a gene derived from Clostridium acetobutylicum.
  • the isopropyl alcohol dehydrogenase in the present invention is classified into enzyme number 1.1.1.180 according to the report of the International Biochemical Union (I.U.B.) Enzyme Committee, and a reaction for producing isopropyl alcohol from acetone. This is a general term for enzymes that catalyze. As such a thing, the thing derived from Clostridium bacteria, such as Clostridium beijerinckii, is mentioned, for example.
  • the isopropyl alcohol dehydrogenase gene introduced into the host bacterium of the present invention was synthesized based on DNA having the base sequence of the gene encoding isopropyl alcohol dehydrogenase obtained from each of the above-mentioned derived organisms or a known base sequence thereof. Synthetic DNA sequences can be utilized. Preferable examples include those derived from Clostridium bacteria, for example, DNA having a base sequence of a gene derived from Clostridium begerinki.
  • the CoA transferase in the present invention is classified into enzyme number 2.8.3.8 based on the report of the International Biochemical Union (I.U.B.) Enzyme Committee, and generates acetoacetate from acetoacetyl CoA.
  • the generic name of the enzyme that catalyzes As such, for example, Clostridium acetobutylicum, Clostridium beijerinckii and other Clostridium bacteria, Roseburia intestinalis such as Roseburia intestinalis, Fakaribacterium, Examples include those derived from genus Facalibacterium such as Faecalibacterium prausnitzii, bacteria belonging to the genus Coprococcus, trypanosoma brucei such as Trypanosoma brucei, and Escherichia coli such as Escherichia coli. It is done.
  • the CoA transferase gene introduced into the host bacterium of the present invention includes a DNA having a base sequence of a gene encoding a CoA transferase obtained from each of the above-described organisms or a synthetic DNA synthesized based on the known base sequence.
  • Arrays can be used. Suitable examples include Clostridium bacteria such as Clostridium acetobutylicum, Roseburia bacteria such as Roseburia intestinalis, Facalibacteria bacteria such as Fakaribacterium plausents, Coprococcus bacteria, Trypanosoma brucei, etc.
  • DNA having the base sequence of a gene derived from a bacterium belonging to the genus Escherichia such as Trypanosoma cerevisiae and Escherichia coli is exemplified. More preferable examples include those derived from Clostridium bacteria or Escherichia bacteria, and particularly preferred is DNA having a base sequence of a gene derived from Clostridium acetobutylicum or Escherichia coli.
  • the thiolase in the present invention is classified into enzyme number 2.3.1.9 based on the report of the International Biochemical Union (I.U.B.) Enzyme Committee, and a reaction for producing acetoacetyl CoA from acetyl CoA.
  • This is a general term for enzymes that catalyze.
  • Bacteria, Zoogloea ramigera bacteria such as Zoogloea ramigera, Rhizobium sp.
  • a DNA having a base sequence of a gene encoding a thiolase obtained from each of the aforementioned derived organisms or a synthetic DNA sequence synthesized based on the known base sequence is used. Can be used.
  • Clostridium bacteria such as Clostridium acetobutylicum and Clostridium beigerinki
  • Escherichia bacteria such as Escherichia coli
  • Halobacteria species Zogroa bacteria such as Zugroa lamigera, Rhizobium species bacteria, Brady Rhizobium japonicam and other bradyrizobium bacteria, Candida tropicalis and other Candida bacteria
  • Caulobacter and Clecentus and other Caulobacter bacteria Streptomyces and Corinus and other Streptomyces bacteria and Enterococcus faecalis
  • DNA having a base sequence of a gene derived from Enterococcus bacteria such as. More preferable examples include those derived from Clostridium bacteria or Escherichia bacteria, and particularly preferred is DNA having a base sequence of a gene derived from Clostridium acetobutylicum or Escherichia coli.
  • the four types of enzymes are preferably derived from at least one selected from the group consisting of Clostridium bacteria, Bacillus bacteria, and Escherichia bacteria, from the viewpoint of enzyme activity.
  • the acetic acid decarboxylase and isopropyl alcohol dehydrogenase are derived from Clostridium bacteria and the CoA transferase activity and the thiolase activity are derived from Escherichia bacteria, and these four types of enzymes are all derived from Clostridium bacteria. preferable.
  • the four types of enzymes according to the present invention are preferably derived from any one of Clostridium acetobutylicum, Clostridium beijurinki or Escherichia coli, and acetoacetate decarboxylase is derived from Clostridium acetobutylicum.
  • the CoA transferase and the thiolase are each an enzyme derived from Clostridium acetobutylicum or Escherichia coli
  • the isopropyl alcohol dehydrogenase is an enzyme derived from Clostridium begerinki
  • the above four types of enzymes are: From the viewpoint of enzyme activity, the acetoacetate decarboxylase activity is derived from Clostridium acetobutylicum, Genaze activity is derived from Clostridium beijerinckii, and particularly preferably CoA transferase activity and thiolase activity is derived from Escherichia coli.
  • the enzyme activity involved in the production of isopropyl alcohol is enhanced, and examples of Escherichia coli that produces isopropyl alcohol include the pIPA / B strain and pIaaa / B strain described in WO2009 / 008377.
  • the promoter of the gene in the present invention is not limited as long as it can control the expression of any of the above genes, but it is a strong promoter that constantly functions in microorganisms and is suppressed in the presence of glucose.
  • Specific examples of such promoters include glyceraldehyde 3-phosphate dehydrogenase (hereinafter sometimes referred to as GAPDH) promoter and serine hydroxymethyltransferase promoter.
  • GAPDH glyceraldehyde 3-phosphate dehydrogenase
  • serine hydroxymethyltransferase promoter serine hydroxymethyltransferase promoter.
  • the promoter in the present invention means a site where RNA polymerase having sigma factor binds and initiates transcription.
  • the GAPDH promoter derived from Escherichia coli is represented by base numbers 397 to 440 in the base sequence information of GenBank accession number X02662.
  • the CoA transferase gene (atoD and atoA) derived from E. coli and the thiolase gene (atoB) form an operon on the E. coli genome in the order of atoD, atoA, and atoB (Journal of Baceteriology Vol. 169 pp 42-52 Lauren Sallus Jenkins et al.) It is possible to simultaneously control the expression of the CoA transferase gene and the thiolase gene by modifying the promoter of atoD. Therefore, when the CoA transferase activity and the thiolase activity are obtained from the genome gene of host E.
  • the promoter responsible for the expression of both enzyme genes is compared with other promoters from the viewpoint of obtaining sufficient isopropyl alcohol production ability. It is preferable to enhance the expression of both enzyme genes by substitution or the like.
  • Examples of the promoter used for enhancing the CoA transferase activity and the thiolase activity include the aforementioned Escherichia coli-derived GAPDH promoter.
  • glucose-6-phosphate-1-dehydrogenase (Zwf) in the present invention is the enzyme number 1.1.1.149 according to the report of the International Biochemical Union (IUB) enzyme committee. It is a generic term for enzymes that catalyze the reaction that is classified and produces D-glucono-1,5-lactone-6-phosphate from D-glucose-6-phosphate.
  • Deinococcus spp such as Deinococcus radiophilus, Aspergillus niger, Aspergillus genus such as Aspergillus aculeatus, Acetobacter genus, such as Acetobacter hansenii, Thermotoga genus, such as Thermotoga maritima, Cryptococcus genus, such as Cryptococcus neoformans Fungi, Dictyostelium genus such as Dictyostelium discoideum, Pseudomonas genus such as Pseudomonas fluorescens, Pseudomonas aeruginosa, Saccharomyces ce Saccharomyces genus such evisiae, Bacillus genus, such as Bacillus megaterium, include those derived from Escherichia genus such as Escherichia coli.
  • the glucose-6-phosphate-1-dehydrogenase (Zwf) gene used in the present invention is based on DNA having a base sequence of a gene encoding a thiolase obtained from each of the aforementioned derived organisms or a known base sequence thereof. Synthetic DNA sequences synthesized in this way can be used.
  • Deinococcus spp such as Deinococcus radiophilus, Aspergillus niger, Aspergillus genus such as Aspergillus aculeatus, Acetobacter genus, such as Acetobacter hansenii, Thermotoga genus, such as Thermotoga maritima, Cryptococcus genus, such as Cryptococcus neoformans, Dictyostelium Dictyosterium genus such as discoidideum, Pseudomonas genus such as Pseudomonas fluorescens, Pseudomonas aeruginosa, Saccharomyces c Saccharomyces genus such revisiae, Bacillus genus, such as Bacillus megaterium, DNA having the nucleotide sequence of the Escherichia genus derived from genes such as Escherichia coli can be exemp
  • More preferable examples include those derived from prokaryotes such as Deinococcus, Aspergillus, Acetobacterium, Thermotoga, Pseudomonas, Bacillus, and Escherichia. This is a DNA having a base sequence of a gene derived from Escherichia coli.
  • the activity of these enzymes in the present invention can be determined by enhancing the promoter activity of an enzyme gene introduced from outside the microbial cell into the microbial cell, or by replacing it with another promoter. It can be expressed strongly.
  • Sucrose non-PTS in the present invention refers to one of the mechanisms by which microorganisms assimilate sucrose. According to the conventional knowledge, the mechanism by which microorganisms assimilate sucrose is roughly classified into sucrose PTS (Phosphoenolpyruvate: ateCarbohydrate Phosphotransferase System) and sucrose non-PTS (see JP 2001-346578 A).
  • sucrose PTS Phosphoenolpyruvate: ateCarbohydrate Phosphotransferase System
  • sucrose non-PTS see JP 2001-346578 A.
  • Sucrose non-PTS is cscB (captures sucrose), cscA (decomposes sucrose inside the microorganism), cscK (permits fructose phosphorylation), cscR (controls the expression of cscB, A, K) It is known to be composed of two factors.
  • Sucrose PTS is scrA (captures sucrose), scrY (performs phosphorylation of sucrose), scrB (decomposes sucrose inside the microorganism), scrR (controls the expression of scrA, Y, B), It is known to be composed of five factors, scrK (which phosphorylates fructose).
  • the isopropyl alcohol-producing Escherichia coli of the present invention preferably has at least a sucrose hydrolase gene in the sucrose non-PTS gene group. This gives the ability to assimilate sucrose to E. coli that cannot assimilate sucrose. As a result, sugarcane and sugar beet can be used as raw materials, and isopropyl alcohol can be obtained from sucrose that can be supplied in large quantities at low cost.
  • the isopropyl alcohol-producing E. coli of the present invention is more efficient because it can produce isopropyl alcohol by assimilating glucose and fructose, which are degradation products of sucrose, almost simultaneously. Examples of Escherichia coli that does not originally have sucrose utilization ability include K12 strain, B strain, C strain and its derived strain.
  • the sucrose non-PTS gene group refers to a gene group involved in a non-PTS system in the sucrose utilization pathway of microorganisms. Specifically, it is a gene group composed of a repressor protein (cscR), sucrose hydrolase (cscA), fructokinase (cscK), and sucrose permease (cscB). Especially, in order to use sucrose efficiently, it is preferable to have only the gene encoding cscA and not to include other genes.
  • cscR repressor protein
  • cscA sucrose hydrolase
  • cscK fructokinase
  • cscB sucrose permease
  • sucrose hydrolase invertase, CscA
  • CscA The sucrose hydrolase invertase, CscA
  • IUB International Biochemical Union
  • sucrose permease sucrose hydrolase
  • fructokinase The sucrose hydrolase-specific repressor.
  • sucrose outside the cell is decomposed into glucose and fructose possibly near the cell membrane and released to the outside of the cell, and glucose PTS and fructose PTS are released. Via phosphorylation into the cytoplasm.
  • fructose can be supplied to the fructose metabolism system in bacteria and assimilation utilizing the glycolysis system becomes possible.
  • the sucrose hydrolase (invertase, CscA) gene introduced into the host bacterium of the present invention has a base sequence of a gene encoding sucrose hydrolase (invertase, CscA) obtained from an organism having this enzyme.
  • DNA or a synthetic DNA sequence synthesized based on its known base sequence can be used. Preferred are: Erwinia, Porteus, Proteus, Vibrio, Agrobacterium, Rhizobium, Staphylococcus (Staphylococcus) ), And those derived from Bifidobacterium and Escherichia. Examples include DNA having the base sequence of a gene derived from Escherichia coli O157 strain.
  • DNA having a base sequence of a gene derived from Escherichia coli O157 strain.
  • a signal sequence for transferring cscA to the periplasm of the microbial cell is added to cscA.
  • the gene for the repressor protein (CscR) introduced into the host bacterium of the present invention includes DNA having the base sequence of the gene encoding the repressor protein (CscR) obtained from an organism having this enzyme, or a known one thereof
  • a synthetic DNA sequence synthesized based on the base sequence can be used. Preferred are: Erwinia, Porteus, Proteus, Vibrio, Agrobacterium, Rhizobium, Staphylococcus (Staphylococcus) ), And those derived from Bifidobacterium and Escherichia.
  • Examples include DNA having the base sequence of a gene derived from Escherichia coli O157 strain. Particularly preferred is DNA having a base sequence of a gene derived from Escherichia coli O157 strain.
  • fructokinase (CscK) gene to be introduced into the host bacterium of the present invention
  • a synthetic DNA sequence synthesized based on the base sequence can be used.
  • Preferred are: Erwinia, Porteus, Proteus, Vibrio, Agrobacterium, Rhizobium, Staphylococcus (Staphylococcus) ), And those derived from Bifidobacterium and Escherichia.
  • Examples include DNA having the base sequence of a gene derived from Escherichia coli O157 strain. Particularly preferred is DNA having a base sequence of a gene derived from Escherichia coli O157 strain.
  • the sucrose permease (CscB) gene to be introduced into the host bacterium of the present invention is a DNA having a base sequence of a gene encoding sucrose permease (CscB) obtained from an organism having this enzyme, or A synthetic DNA sequence synthesized based on a known base sequence can be used. Preferred are: Erwinia, Porteus, Proteus, Vibrio, Agrobacterium, Rhizobium, Staphylococcus (Staphylococcus) ), And those derived from Bifidobacterium and Escherichia. Examples include DNA having the base sequence of a gene derived from Escherichia coli O157 strain. Particularly preferred is DNA having a base sequence of a gene derived from Escherichia coli O157 strain.
  • sucrose assimilation refers to the ability of sucrose to be reduced in molecular weight or polymerized as it is, preferably reduced in molecular weight and taken into the living body, or metabolically converted to another substance. Further, in the present invention, assimilation includes decomposition that lowers the molecular weight of sucrose. Specifically, it includes breaking down sucrose into D-glucose and D-fructose.
  • the introduction of the enzyme activity can be carried out, for example, by introducing genes encoding these four types of enzymes into the cells from outside the host bacteria using genetic recombination techniques.
  • the introduced enzyme gene may be the same or different from the host cell.
  • Preparation of genomic DNA necessary for introducing a gene from outside the cell into the cell DNA cleavage and ligation, transformation, PCR (Polymerase® Chain® Reaction), design of oligonucleotides used as primers, synthesis, etc. This can be done by conventional methods well known to those skilled in the art. These methods are described in Sambrook, J., et al., Molecular CloninglonA Laboratory Manual, Second Edition ”, Cold Spring Harbor Laboratory Press, (1989).
  • E. coli to which an enzyme activity is imparted refers to E. coli to which the enzyme activity has been imparted by some method from outside the cell body.
  • Escherichia coli can be produced, for example, using a method such as introducing the genes encoding the enzymes and proteins into the cells from outside the cells using the same gene recombination technique as described above.
  • E. coli with enhanced enzyme activity refers to E. coli with enhanced enzyme activity by some method.
  • These Escherichia coli for example, introduce a gene encoding the enzyme and protein by using a gene recombination technique similar to that described above from outside the cell body using a plasmid, or the host E. coli is placed on the genome.
  • the enzyme gene can be produced by a method such as enhancing the promoter activity of the enzyme gene possessed or by strongly expressing the enzyme gene by replacing it with another promoter.
  • Escherichia coli originally refers to E. coli that can have the ability to produce isopropyl alcohol from plant-derived materials by using any means, regardless of whether or not it has the ability to produce isopropyl alcohol from plant-derived materials. means.
  • the Escherichia coli to be introduced into each of the above genes may not have isopropyl alcohol production ability, and any Escherichia coli may be used as long as introduction and modification of each of the above genes can be performed. . More preferably, it can be Escherichia coli preliminarily provided with the ability to produce isopropyl alcohol, whereby isopropyl alcohol can be produced more efficiently.
  • isopropyl alcohol-producing Escherichia coli for example, acetoacetate decarboxylase activity, isopropyl alcohol dehydrogenase activity, CoA transferase activity, and thiolase activity described in International Publication No. 2009/008377 pamphlet are imparted, and isopropyl alcohol is produced from plant-derived materials. Examples include isopropyl alcohol-producing Escherichia coli that can produce alcohol.
  • the isopropyl alcohol production method of the present invention includes producing isopropyl alcohol from a plant-derived material using the isopropyl alcohol-producing Escherichia coli, that is, contacting the isopropyl alcohol-producing Escherichia coli with a plant-derived material, It includes a culturing step and a recovery step of recovering isopropyl alcohol obtained by contact.
  • the plant-derived material used in the above isopropyl alcohol production method is a carbon source obtained from a plant, and is not particularly limited as long as it is a plant-derived material.
  • it refers to organs such as roots, stems, trunks, branches, leaves, flowers, seeds, plants containing them, degradation products of these plant organs, and further from plant bodies, plant organs, or degradation products thereof.
  • the obtained carbon sources those that can be used as a carbon source in culture by microorganisms are also included in plant-derived materials.
  • Carbon sources included in such plant-derived materials generally include sugars such as starch, sucrose, glucose, fructose, xylose, arabinose, or herbaceous degradation products containing a large amount of these components, cellulose hydrolysates. Or a combination thereof, and also glycerin or fatty acid derived from vegetable oil may be included in the carbon source in the present invention.
  • Examples of plant-derived materials in the present invention can preferably include crops such as cereals, corn, rice, wheat, soybeans, sugar cane, beet, cotton, etc., or a combination thereof, There are no particular restrictions on raw products, juice, pulverized products, and the like. Moreover, the form of only the above-mentioned carbon source may be sufficient.
  • the contact between the isopropyl alcohol-producing Escherichia coli and the plant-derived material in the culturing step is performed by culturing the isopropyl alcohol-producing Escherichia coli in a medium containing the plant-derived material.
  • the contact density between the plant-derived material and isopropyl alcohol-producing E. coli varies depending on the activity of the isopropyl alcohol-producing E. coli, but in general, the initial sugar concentration in terms of glucose relative to the total mass of the mixture as the concentration of the plant-derived material in the medium. From the viewpoint of E. coli sugar resistance, the initial sugar concentration can be preferably 15 mass% or less. Each of these other components may be added in an amount usually added to the microorganism medium, and is not particularly limited.
  • a carbon source As a medium used for culturing isopropyl alcohol-producing Escherichia coli, a carbon source, a nitrogen source, inorganic ions, and organic trace elements required by microorganisms to produce isopropyl alcohol, nucleic acids, vitamins and the like are usually used. If it is a culture medium, there will be no restriction
  • the culture conditions are not particularly limited.
  • the pH is 4 to 9, preferably 6 to 8, and the temperature is 20 ° C. to 50 ° C., preferably 25 ° C. to 42 ° C. under aerobic conditions. And culturing while appropriately controlling the temperature.
  • the amount of gas flow into the mixture is not particularly limited. However, when only air is used as the gas, generally 0.02 vvm to 2.0 vvm (vvm; aeration capacity [mL] / liquid capacity [mL] ] / Hour [minute]), and from the viewpoint of suppressing physical damage to E. coli, it is preferably performed at 0.1 vvm to 1.5 vvm.
  • the culture process can be continued from the start of culture until the plant-derived raw material in the mixture is consumed or until the activity of the isopropyl alcohol-producing Escherichia coli ceases.
  • the period of the culturing step varies depending on the number and activity of isopropyl alcohol-producing Escherichia coli in the mixture and the amount of plant-derived raw material, but is generally 1 hour or longer, preferably 4 hours or longer.
  • the culture period can be continued indefinitely, but from the viewpoint of treatment efficiency, it is generally 5 days or less, preferably 55 hours or less. it can.
  • the conditions used for normal culture may be applied as they are.
  • the method for recovering the isopropyl alcohol accumulated in the culture solution is not particularly limited.
  • the isopropyl alcohol is separated by a conventional separation method such as distillation or membrane separation. Can be used.
  • the method for producing isopropyl alcohol of the present invention includes a pre-culture step for bringing the isopropyl alcohol-producing Escherichia coli to be used into an appropriate number of cells or an appropriate active state before the culture step for producing isopropyl alcohol. May be.
  • the pre-culture process may be a culture under the culture conditions normally used according to the type of isopropyl alcohol-producing bacterium.
  • the isopropyl alcohol production method of the present invention is preferably produced by culturing the isopropyl alcohol-producing Escherichia coli while supplying gas into the mixture containing the isopropyl alcohol-producing bacteria and the plant-derived raw material, and the culture.
  • the produced E. coli is cultured while supplying gas to the mixture (aeration culture).
  • the produced isopropyl alcohol is released into the mixture and evaporated from the mixture.
  • the produced isopropyl alcohol can be easily separated from the mixture.
  • separates continuously from a mixture, the raise of the density
  • E._coli is just to use the basic medium generally used for culture
  • the above-mentioned matters are applied as they are.
  • isopropyl alcohol produced in the culture step and separated from the mixture is recovered.
  • Any recovery method may be used as long as it can collect gaseous or droplets of isopropyl alcohol evaporated from the mixture by normal culture. Examples of such a method include storing in a commonly used collection member such as a sealed container, etc. Among them, from the viewpoint that only isopropyl alcohol can be recovered with high purity, capturing for capturing isopropyl alcohol. It preferably includes contacting the liquid with isopropyl alcohol separated from the mixture.
  • isopropyl alcohol can be recovered as a form dissolved in a capture solution or mixture.
  • a recovery method include the method described in International Publication No. 2009/008377.
  • the recovered isopropyl alcohol can be confirmed using ordinary detection means such as HPLC.
  • the recovered isopropyl alcohol can be further purified as necessary. Examples of such a purification method include distillation.
  • the isopropyl alcohol production method may further include a dehydration step in addition to the recovery step. Isopropyl alcohol can be dehydrated by a conventional method.
  • FIG. 1 of International Publication No. 2009/008377 As an apparatus applicable to the production method of isopropyl alcohol which can be recovered as a form dissolved in a capture liquid or a mixture, for example, a production apparatus shown in FIG. 1 of International Publication No. 2009/008377 can be given.
  • an infusion tube for injecting gas from the outside of the apparatus is connected to a culture tank in which a culture medium containing isopropyl alcohol-producing bacteria and plant-derived raw materials is contained, and aeration can be performed on the culture medium. Yes.
  • the trap tank in which the trap liquid as a capture liquid is accommodated is connected to the culture tank via a connecting tube.
  • cultivation in a culture tank is evaporated by aeration, and is easily isolate
  • isopropyl alcohol can be continuously and conveniently produced in a more purified form.
  • isopropyl alcohol in the method for producing isopropyl alcohol of the present invention, isopropyl alcohol can be produced with high purity, and the content of by-products usually obtained by the same method, for example, acetone, is low compared to the case where the present invention is not applied. .
  • all products (excluding gas and water) released from the inside of the cell body using the metabolic pathway of E. coli at the end of the culture process The proportion of isopropyl alcohol can be 65 mass% to 100 mass%, preferably 80 mass% to 100 mass%.
  • the ratio of the amount of byproduct acetone and isopropyl alcohol produced at the end of the culturing step is from 0 to the amount of byproduct acetone produced (g / L) when the amount of produced isopropyl alcohol (g / L) is 1. It can be 0.4, preferably 0 to 0.2.
  • the product obtained by the isopropyl alcohol production method of the present invention has a low ratio of by-products such as acetone to isopropyl alcohol, and thus, for example, from a plant-derived raw material in the presence of a solid acid substance and a hydrogenation catalyst.
  • propylene is produced from isopropyl alcohol containing acetone produced by isopropyl alcohol-producing bacteria, the amount of hydrogen used for hydrogenation of acetone can be reduced.
  • Example 1 ⁇ Preparation of Escherichia coli B strain ⁇ pgi strain> The entire base sequence of the genomic DNA of Escherichia coli is known (GenBank accession number U00096), and the base sequence of the gene encoding Escherichia coli phosphoglucose isomerase (hereinafter sometimes referred to as pgi) has also been reported ( GenBank accession number X15196).
  • nucleotide sequence region near the gene (1,650Bp) encoding pgi caggaattcgctatatctggctctgcacg (SEQ ID NO: 1), cagtctagagcaatactcttctgattttgag (SEQ ID NO: 2), oligo shown in Shieijitictagatcatcgtcgatatgtaggcc (SEQ ID NO: 3) and Jieishishitgcagatcatccgtcagctgtacgc (SEQ ID NO: 4) Four types of nucleotide primers were synthesized.
  • the primer of SEQ ID NO: 1 has an EcoRI recognition site on the 5 ′ end side
  • the primers of SEQ ID NOS: 2 and 3 have an XbaI recognition site on the 5 ′ end side
  • the primer of SEQ ID NO: 4 has a PstI recognition site on the 5 ′ end side, respectively.
  • a genomic DNA of Escherichia coli MG1655 strain was prepared, and the obtained genomic DNA was used as a template, and PCR was performed with a primer pair of SEQ ID NO: 1 and SEQ ID NO: 2 to amplify a DNA fragment of about 1.0 kb. (Hereinafter sometimes referred to as pgi-L fragment).
  • pgi-L fragment a DNA fragment of about 1.0 kb was amplified by PCR using the primer pair of SEQ ID NO: 3 and SEQ ID NO: 4 (hereinafter sometimes referred to as pgi-R fragment).
  • DNA fragments were separated and collected by agarose electrophoresis, and the pgi-L fragment was digested with EcoRI and XbaI, and the pgi-R fragment was digested with XbaI and PstI, respectively.
  • the two digested fragments were mixed with EcoRI and PstI digests of the temperature sensitive plasmid pTH18cs1 (GenBank accession number AB019610), reacted with T4 DNA ligase, and transformed into Escherichia coli DH5 ⁇ competent cell (manufactured by Toyobo Co., Ltd.).
  • a transformant was obtained that grew on an LB agar plate containing 10 ⁇ g / ml of chloramphenicol at 30 ° C.
  • a plasmid was recovered from the obtained transformant, and it was confirmed that two fragments, a 5 ′ upstream vicinity fragment and a 3 ′ downstream vicinity fragment of the gene encoding pgi were correctly inserted into pTH18cs1.
  • the obtained plasmid was digested with XbaI, and then blunt-ended with T4 DNA polymerase.
  • This DNA fragment was ligated with T4 DNA ligase to the pUC4K plasmid (GenBank accession number X06404) (Pharmacia) digested with EcoRI and the kanamycin resistance gene further blunt-ended with T4 DNA polymerase. did. Thereafter, the cells were transformed into Escherichia coli DH5 ⁇ competent cells to obtain transformants that grew at 30 ° C. on LB agar plates containing chloramphenicol 10 ⁇ g / ml and kanamycin 50 ⁇ g / ml. The plasmid was recovered from the obtained transformant, and it was confirmed that the kanamycin resistance gene was correctly inserted between the 5 ′ upstream vicinity fragment and the 3 ′ downstream vicinity fragment of the gene encoding pgi.
  • the thus obtained plasmid was transformed into Escherichia coli B strain (ATCC 11303) and cultured overnight at 30 ° C. on an LB agar plate containing 10 ⁇ g / ml of chloramphenicol and 50 ⁇ g / ml of kanamycin to obtain a transformant. It was.
  • the obtained transformant was inoculated into an LB liquid medium containing kanamycin 50 ⁇ g / ml and cultured at 30 ° C. overnight. Next, a part of this culture solution was applied to an LB agar plate containing kanamycin 50 ⁇ g / ml to obtain colonies that grew at 42 ° C.
  • the obtained colonies were cultured in an LB liquid medium containing 50 ⁇ g / ml of kanamycin for 24 hours at 30 ° C., and further applied to an LB agar plate containing 50 ⁇ g / ml of kanamycin to obtain colonies that grew at 42 ° C.
  • Escherichia coli MG1655 strain and Escherichia coli B strain can be obtained from American Type Culture Collection.
  • Example 2 ⁇ Construction of Escherichia coli-derived thiolase gene, Escherichia coli-derived CoA transferase gene, Clostridium bacteria-derived acetoacetate decarboxylase gene, Clostridium bacteria-derived isopropyl alcohol dehydrogenase gene expression vector and the expression vector transformant>
  • the amino acid sequence of Escherichia coli thiolase and the Escherichia coli CoA transferase have already been reported. That is, a gene encoding a thiolase is described in 2324131 to 2325315 of the Escherichia coli MG1655 strain genomic sequence described in GenBank accession number U00096.
  • the gene encoding CoA transferase is described in the above-described genome sequence of Escherichia coli MG1655 strain 232469-2322781. Together with these, isopropyl alcohol can be produced by expressing the acetoacetate decarboxylase gene and isopropyl alcohol dehydrogenase gene derived from Clostridium bacteria described later.
  • As a base sequence of a promoter necessary for expressing the above gene group glyceraldehyde 3-phosphate dehydrogenase derived from Escherichia coli described in 397 to 440 in the base sequence information of GenBank accession number X02662 Promoter sequence (sometimes referred to as GAPDH).
  • Cgagctatacatgcaatgattgacagattttccg (SEQ ID NO: 5) and cgcgcgcatgctattttgtttgattagaag (SEQ ID NO: 6) were obtained by PCR using the genomic DNA of Escherichia coli MG1655 strain as a template.
  • a DNA fragment corresponding to the GAPDH promoter of about 110 bp was obtained by digestion with SphI.
  • the resulting DNA fragment and the plasmid pBR322 (GenBank accession number J01749) were mixed with fragments obtained by digesting with restriction enzymes NdeI and SphI, ligated with ligase, and then Escherichia coli DH5 ⁇ strain competent cell (Toyo) Spinning Co., Ltd. DNA-903) was transformed to obtain a transformant that grew on an LB agar plate containing 50 ⁇ g / mL of ampicillin. The obtained colonies were cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid pBRgapP was recovered from the obtained cells.
  • the genomic DNA of Clostridium beijerinckii R NRRL B-593 was used as a template.
  • the fragment was digested with restriction enzymes SphI and BamHI to obtain an isopropyl alcohol dehydrogenase fragment of about 1.1 kbp.
  • the obtained DNA fragment and the previously prepared plasmid pBRgapP were digested with restriction enzymes SphI and BamHI, mixed together using ligase, and then Escherichia coli DH5 ⁇ strain competent cell (Toyobo Co., Ltd.) Company transformant DNA-903) was transformed to obtain transformants that grew on LB agar plates containing ampicillin 50 ⁇ g / mL.
  • the obtained colonies were cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid pGAP-IPAdh was recovered from the obtained cells.
  • the obtained DNA fragment and the previously prepared plasmid pGAP-IPAdh were digested with restriction enzymes BamHI and HindIII, mixed together using ligase, and then Escherichia coli DH5 ⁇ strain competent cell (Toyo Spinning Co., Ltd. DNA-903) was transformed to obtain a transformant that grew on an LB agar plate containing 50 ⁇ g / mL of ampicillin.
  • Escherichia coli DH5 ⁇ strain competent cell Toyo Spinning Co., Ltd. DNA-903
  • the obtained colonies were cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid pGAP-IPAdh-atoB was recovered from the obtained cells.
  • the resulting DNA fragment and the previously prepared plasmid pGAP-IPAdh-atoB were digested with restriction enzymes XbaI and HindIII, mixed together using ligase, and then Escherichia coli DH5 ⁇ strain competent cell (Toyobo Co., Ltd. Sakai DNA-903) was transformed to obtain a transformant that grew on an LB agar plate containing 50 ⁇ g / mL of ampicillin.
  • the obtained colonies were cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid pGAP-IPAdh-atoB-atoD was recovered from the obtained cells.
  • the obtained DNA fragment and the previously prepared plasmid pGAP-IPAdh-atoB-atoD were digested with restriction enzymes XhoI and HindIII, mixed together using ligase, and then Escherichia coli DH5 ⁇ strain compilation
  • Tent cells (Toyobo Co., Ltd. Sakai DNA-903) were transformed to obtain transformants that grew on LB agar plates containing ampicillin 50 ⁇ g / mL.
  • the obtained colonies were cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid pGAP-IPAdh-atoB-atoD-atoA was recovered from the obtained cells.
  • Clostridium acetobutyricum CCATCC824 genomic DNA was used as a template, the DNA was obtained using the following method: Digestion with restriction enzymes KpnI and BamHI gave an acetoacetate decarboxylase fragment of about 700 bp. The obtained DNA fragment was mixed with the previously prepared plasmid pGAP-IPAdh-atoB-atoD-atoA by digestion with restriction enzymes KpnI and BamHI, ligated with ligase, and then Escherichia coli DH5 ⁇ A strain competent cell (Toyobo Co., Ltd.
  • Sakai DNA-903 was transformed to obtain a transformant that grew on an LB agar plate containing 50 ⁇ g / mL of ampicillin.
  • the obtained colonies were cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid pGAP-Iaaa was recovered from the obtained cells.
  • This plasmid pGAP-Iaaa was transformed into the ⁇ pgi strain competent cell prepared in Example 1 and cultured overnight at 37 ° C. on LB Broth, Miller agar plate containing 50 ⁇ g / mL of ampicillin, thereby allowing Escherichia coli pGAP. -Iaaa / B ⁇ pgi strain was obtained.
  • pGAP-Iaaa was transformed into an Escherichia coli B strain (ATCC11303) competent cell and cultured overnight at 37 ° C. on LB Broth, Miller agar plates containing 50 ⁇ g / mL of ampicillin.
  • -Iaaa / B strain was obtained.
  • Escherichia coli MG1655 strain, Clostridium acetobutyricum ATCC824, and Escherichia coli B strain can be obtained from American Type Culture Collection, which is a cell / microorganism / gene bank.
  • AtoD The entire nucleotide sequence of the genomic DNA of Escherichia coli MG1655 strain is known (GenBank accession number U00096), and the gene encoding the CoA transferase ⁇ subunit of Escherichia coli MG1655 strain (hereinafter sometimes abbreviated as atoD) Base sequences have also been reported. In other words, atoD is described in 23221469 to 2322131 of the Escherichia coli MG1655 strain genome sequence described in GenBank accession number U00096.
  • GAPDH glyceraldehyde 3-phosphate dehydrogenase
  • the genomic DNA of Escherichia coli MG1655 strain was used as a template, and cgctcaattgcaatgattgaacacattttccg (SEQ ID NO: 44) and agagaattcgctattttgttgtgattagagt (SEQ ID NO: 45) were obtained by the PCR method.
  • a DNA fragment encoding the GAPDH promoter of about 100 bp was obtained by digestion with EcoRI.
  • the obtained DNA fragment was mixed with plasmid pUC19 (GenBank accession number X02514) digested with restriction enzyme EcoRI and further treated with alkaline phosphatase, and ligated with ligase, and then Escherichia coli DH5 ⁇ strain competent cell ( Toyobo Co., Ltd. DNA-903) was transformed to obtain transformants that grew on LB agar plates containing ampicillin 50 ⁇ g / mL. Ten colonies obtained were each cultured overnight in an LB liquid medium containing 50 ⁇ g / mL of ampicillin at 37 ° C., the plasmid was recovered, and the GAPDH promoter was not excised when digested with restriction enzymes EcoRI and KpnI.
  • the DNA sequence was confirmed, and the one in which the GAPDH promoter was correctly inserted was designated as pUCgapP.
  • the obtained pUCgapP was digested with restriction enzymes EcoRI and KpnI.
  • the genomic DNA of Escherichia coli MG1655 strain was used as a template to obtain cgaattcgctgggtggagaatatatgaaaaaaaatgacatatacaagac (SEQ ID NO: 46), and the DNA fragment obtained by the gcggtactttttttgctctctgtggt PCR Digestion with EcoRI and KpnI yielded an approximately 690 bp atoD fragment.
  • This DNA fragment was mixed with pUCgapP previously digested with restriction enzymes EcoRI and KpnI, ligated with ligase, transformed into Escherichia coli DH5 ⁇ strain competent cell (Toyobo Co., Ltd. DNA-903), and ampicillin. A transformant that grew on an LB agar plate containing 50 ⁇ g / mL was obtained. A plasmid was recovered from the obtained bacterial cells, and it was confirmed that atoD was correctly inserted. This plasmid was named pGAPatoD. Escherichia coli MG1655 strain can be obtained from the American Type Culture Collection.
  • a primer of SEQ ID NO: 4 prepared on the basis of the sequence information of ggtctagagcaatgattagaacgagtccc (SEQ ID NO: 50) and atoD of Escherichia coli MG1655 strain prepared based on the sequence information of the GAPDH promoter of Escherichia coli MG1655 strain is used. Then, PCR was performed using the expression vector pGAPatoD prepared earlier as a template to obtain a DNA fragment of about 790 bp consisting of the GAPDH promoter and atoD.
  • the fragments obtained above were digested with restriction enzymes PstI and XbaI, XbaI and KpnI, respectively, and this fragment was temperature-sensitive plasmid pTH18cs1 (GenBank accession number AB019610) [Hashimoto-Gotoh, T., Gene, 241, 185-191 (2000)] was mixed with a fragment obtained by digesting with PstI and KpnI, ligated with ligase, transformed into DH5 ⁇ strain, and applied to an LB agar plate containing 10 ⁇ g / ml of chloramphenicol at 30 ° C. A growing transformant was obtained. The obtained colony was cultured overnight at 30 ° C.
  • the obtained colonies were cultured in an LB liquid medium containing no antibiotics at 30 ° C. for 2 hours, and applied to an LB agar plate containing no antibiotics to obtain colonies that grew at 42 ° C. Randomly picked 100 colonies from the colonies that emerged and grown them on LB agar plates containing no antibiotics and LB agar plates containing 10 ⁇ g / ml of chloramphenicol. I chose.
  • the Escherichia coli B strain (ATCC 11303) can be obtained from the American Type Culture Collection, which is a cell / microorganism / gene bank.
  • Cgagctatacatgcaatgattgacagattttccg (SEQ ID NO: 5) and cgcgcgcatgctattttgtttgattagaag (SEQ ID NO: 6) were obtained by PCR using the genomic DNA of Escherichia coli MG1655 strain as a template.
  • a DNA fragment corresponding to the GAPDH promoter of about 110 bp was obtained by digestion with SphI.
  • the resulting DNA fragment was mixed with the plasmid pBR322 (GenBank accession number J01749) digested with restriction enzymes NdeI and SphI, ligated with ligase, and then Escherichia coli DH5 ⁇ strain competent cell (Toyosei) Spinning Co., Ltd. DNA-903) was transformed to obtain transformants that grew on LB agar plates containing ampicillin 50 ⁇ g / mL. The obtained colonies were cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid pBRgapP was recovered from the obtained cells.
  • Clostridium beijerinckii NRRL B-593 genomic DNA was used as a template.
  • the fragment was digested with restriction enzymes SphI and BamHI to obtain an isopropyl alcohol dehydrogenase fragment of about 1.1 kbp.
  • the obtained DNA fragment was mixed with a fragment obtained by digesting the plasmid pBRgapP with restriction enzymes SphI and BamHI, ligated with ligase, and then Escherichia coli DH5 ⁇ strain competent cell (Toyobo Co., Ltd. DNA-903).
  • a transformant that grows on an LB agar plate containing 50 ⁇ g / mL of ampicillin was obtained.
  • the obtained colony was cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid was recovered from the obtained bacterial cells to confirm that IPAdh was correctly inserted. It was named IPAdh.
  • IPAdh In order to obtain the acetoacetate decarboxylase gene, Clostridium acetobutyricum ATCC824 genomic DNA was used as a template, the DNA was obtained by the following method: Digestion with restriction enzymes BamHI and EcoRI gave an acetoacetate decarboxylase fragment of about 700 bp.
  • the obtained DNA fragment and the previously prepared plasmid pGAP-IPAdh were digested with restriction enzymes BamHI and EcoRI, mixed together using ligase, and then Escherichia coli DH5 ⁇ strain competent cell (Toyo Spinning Co., Ltd. DNA-903) was transformed to obtain transformants that grew on LB agar plates containing ampicillin 50 ⁇ g / mL.
  • the obtained colony was cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid was recovered from the obtained bacterial cells to confirm that adc was correctly inserted. Named.
  • the Escherichia coli B strain genomic DNA (GenBank accession No. CP000819) was used as a template.
  • the resulting DNA fragment was digested with restriction enzymes BamHI and XbaI to obtain an about 1500 bp glucose 6-phosphate 1-dehydrogenase fragment.
  • the obtained DNA fragment and the previously prepared plasmid pGAP-Ia were digested with the restriction enzymes BamHI and XbaI, mixed together and ligated using ligase, and then Escherichia coli DH5 ⁇ strain competent cell (Toyobo Co., Ltd.) DNA-903) was transformed to obtain transformants that grew on LB agar plates containing ampicillin 50 ⁇ g / mL.
  • the obtained colony was cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the resulting plasmid was designated as pGAP-Iaz.
  • This plasmid pIaz was transformed into the previously prepared Escherichia coli B :: atoDAB competent cell and cultured overnight at 37 ° C. on an LB Broth, Miller agar plate containing 50 ⁇ g / mL of ampicillin. pGAP-Iaz / B :: toDAB was obtained.
  • Example 3 ⁇ Isopropyl alcohol production from glucose by Escherichia coli pGAP-Iaaa / B strain, pGAP-Iaaa / B ⁇ pgi strain and pGAP-Iaz / B :: atoDAB ⁇ pgi strain using 3 L culture tank>
  • isopropyl alcohol was produced using the production apparatus shown in FIG. 1 of WO2009 / 008377.
  • a culture tank of 3 liters was used, and a trap tank of 10 L was used.
  • the culture tank, trap tank, injection tube, connecting tube, and discharge tube were all made of glass. Water (trap water) as a trap liquid was injected into the trap tank in an amount of 9 L.
  • a waste liquid tube was installed in the culture tank, and the culture liquid increased by feeding of sugar or a neutralizing agent was appropriately discharged out of the culture tank.
  • Culturing was performed under atmospheric pressure with an aeration rate of 0.9 L / min, a stirring speed of 550 rpm, a culture temperature of 30 ° C., and a pH of 7.0 (adjusted with NH 3 aqueous solution).
  • a 45 wt / wt% aqueous glucose solution was added at a flow rate of 7.5 g / L / hour.
  • a 45 wt / wt% aqueous glucose solution was added at a flow rate of 15 g / L / hour.
  • the cell culture solution was sampled 120 hours after the start of the culture, and after removing the cells by centrifugation, the amount of product accumulated in the obtained culture supernatant was measured by HPLC according to a standard method.
  • a measured value is a total value in the culture solution after culture
  • Table 1 shows the concentration of the product after culture and the purity of isopropyl alcohol.
  • glucose-6-phosphate isomerase is completely inactivated by destroying the gene (pgi) encoding glucose-6-phosphate isomerase inherent in E. coli, and the purity of isopropyl alcohol is reduced. It was confirmed to improve. It was also found that the purity of isopropyl alcohol was further improved by destroying pgi and enhancing the expression of the glucose-6-phosphate-1-dehydrogenase gene (zwf).
  • zwf glucose-6-phosphate-1-dehydrogenase gene
  • the ttggtaccttttacacatgctgtcccccccccccc (SEQ ID NO: 17), cgtctatagatagctgtattcatgcatgg (SEQ ID NO: 18), and Four types were synthesized.
  • the primer of SEQ ID NO: 17 has a KpnI recognition site on the 5 ′ end side
  • the primers of SEQ ID NOS: 18 and 19 have an XbaI recognition site on the 5 ′ end side
  • the primer of SEQ ID NO: 20 has a PstI recognition site on the 5 ′ end side.
  • a genomic DNA of Escherichia coli MG1655 strain was prepared, and the obtained genomic DNA was used as a template, and a DNA fragment of about 1.0 kb was amplified by PCR using the primer pair of SEQ ID NO: 17 and SEQ ID NO: 18. (Hereinafter sometimes referred to as the pfkB-L fragment). In addition, a DNA fragment of about 1.0 kb was amplified by PCR using the primer pair of SEQ ID NO: 19 and SEQ ID NO: 20 (hereinafter sometimes referred to as pfkB-R fragment).
  • a transformant was obtained that grew on an LB agar plate containing 10 ⁇ g / ml of chloramphenicol at 30 ° C.
  • the plasmid was recovered from the obtained transformant, and it was confirmed that two fragments, a 5 'upstream vicinity fragment and a 3' downstream vicinity fragment of the gene encoding pfkB were correctly inserted into pTH18cs1.
  • the obtained plasmid was digested with XbaI, and then blunt-ended with T4 DNA polymerase.
  • the DNA of cagctgactcgacatcttgtgtgtaccg (SEQ ID NO: 21) and cagctgcaaggggtgtattattttcg (SEQ ID NO: 22) was obtained by using the DNA as a DNA fragment.
  • the plasmid was treated with polynucleotide kinase and ligated with the above blunt-ended plasmid. Subsequently, the cells were transformed into Escherichia coli DH5 ⁇ competent cells to obtain transformants that grew at 30 ° C.
  • the thus obtained plasmid was transformed into Escherichia coli B strain (ATCC11303) and cultured overnight on an LB agar plate containing chloramphenicol at a concentration of 10 ⁇ g / ml at 30 ° C. to obtain a transformant.
  • the obtained transformant was inoculated into an LB liquid medium containing 20 ⁇ g / ml of tetracycline and cultured at 30 ° C. overnight.
  • a part of this culture solution was applied to an LB agar plate containing 20 ⁇ g / ml of tetracycline to obtain colonies that grew at 42 ° C.
  • the obtained colonies were cultured in an LB liquid medium containing 20 ⁇ g / ml of tetracycline for 24 hours at 30 ° C., and further applied to an LB agar plate containing 20 ⁇ g / ml of tetracycline to obtain colonies that grew at 42 ° C.
  • PCR was performed using primer pair SEQ ID NO: 17 and SEQ ID NO: 20 for amplifying an approximately 3.0 kbp fragment in the vicinity of the pfkB gene including the pfkB gene in the wild strain B strain, and pfkB A strain that can amplify an about 3.2 kbp fragment was selected by replacing the gene with a tetracycline resistance gene.
  • the obtained strain was named B strain pfkB gene deletion strain (hereinafter sometimes abbreviated as ⁇ pfkB strain).
  • the atctgcagtactagcgtcagttgatagc SEQ ID NO: 23
  • cgtctatagatgactgtacatgatgagtgagtgagtgagtgagtgat SEQ ID NO: 24
  • the primer of SEQ ID NO: 23 has a PstI recognition site on the 5 ′ end side
  • the primers of SEQ ID NOS: 24 and 25 have an XbaI recognition site on the 5 ′ end side
  • the primer of SEQ ID NO: 26 has a KpnI recognition site on the 5 ′ end side.
  • a genomic DNA of Escherichia coli MG1655 strain was prepared, and the obtained genomic DNA was used as a template, and PCR was performed with a primer pair of SEQ ID NO: 23 and SEQ ID NO: 24 to amplify a DNA fragment of about 1.0 kb. (Hereinafter sometimes referred to as a pfkA-L fragment).
  • a DNA fragment of about 1.0 kb was amplified by PCR using the primer pair of SEQ ID NO: 25 and SEQ ID NO: 26 (hereinafter sometimes referred to as pfkA-R fragment).
  • DNA fragments were separated and collected by agarose electrophoresis, and the pfkA-L fragment was digested with PstI and XbaI, and the pfkA-R fragment was digested with XbaI and KpnI, respectively.
  • the two digested fragments were mixed with KpnI and PstI digests of temperature sensitive plasmid pTH18cs1 (GenBank accession number AB019610), reacted with T4 DNA ligase, and transformed into Escherichia coli DH5 ⁇ competent cell (manufactured by Toyobo Co., Ltd.).
  • a transformant was obtained that grew on an LB agar plate containing 10 ⁇ g / ml of chloramphenicol at 30 ° C.
  • a plasmid was recovered from the obtained transformant, and it was confirmed that two fragments, a 5 'upstream vicinity fragment and a 3' downstream vicinity fragment of the gene encoding pfkA were correctly inserted into pTH18cs1.
  • the obtained plasmid was digested with XbaI, and then blunt-ended with T4 DNA polymerase.
  • This DNA fragment and the pUC4K plasmid (GenBank accession number X06404) (Pharmacia) digested with EcoRI and the kanamycin resistance gene further blunt-ended with T4 DNA polymerase were ligated using T4 DNA ligase. did. Thereafter, the cells were transformed into Escherichia coli DH5 ⁇ competent cells to obtain transformants that grew at 30 ° C. on LB agar plates containing chloramphenicol 10 ⁇ g / ml and kanamycin 50 ⁇ g / ml. A plasmid was recovered from the obtained transformant, and it was confirmed that the kanamycin resistance gene was correctly inserted between the 5 'upstream vicinity fragment and the 3' downstream vicinity fragment of the gene encoding pfkA.
  • the thus obtained plasmid was transformed into Escherichia coli ⁇ pfkB strain and cultured overnight at 30 ° C. on an LB agar plate containing 10 ⁇ g / ml of chloramphenicol and 50 ⁇ g / ml of kanamycin to obtain a transformant.
  • the obtained transformant was inoculated into an LB liquid medium containing kanamycin 50 ⁇ g / ml and cultured at 30 ° C. overnight. Next, a part of this culture solution was applied to an LB agar plate containing kanamycin 50 ⁇ g / ml to obtain colonies that grew at 42 ° C.
  • the obtained colonies were cultured in an LB liquid medium containing 50 ⁇ g / ml of kanamycin for 24 hours at 30 ° C., and further applied to an LB agar plate containing 50 ⁇ g / ml of kanamycin to obtain colonies that grew at 42 ° C.
  • PCR was performed using primer pair SEQ ID NO: 7 and SEQ ID NO: 10 for amplifying an approximately 3.0 kbp fragment in the vicinity of the pfkA gene including the pfkA gene in the wild type B strain, and pfkA A strain that can amplify an about 3.1 kbp fragment by selecting a gene for the kanamycin resistance gene was selected.
  • the obtained strain was named B strain pfkA, pfkB gene deletion strain (hereinafter sometimes abbreviated as ⁇ pfkA ⁇ pfkB strain).
  • Escherichia coli MG1655 strain and Escherichia coli B strain can be obtained from American Type Culture Collection.
  • the cell culture solution was sampled 120 hours after the start of the culture, and after removing the cells by centrifugation, the amount of product accumulated in the obtained culture supernatant was measured by HPLC according to a standard method. In addition, a measured value is a total value in the culture solution after culture
  • Example 3 the purity of isopropyl alcohol is improved when the gene (pgi) encoding glucose-6-phosphate isomerase, which is one of the glycolytic enzymes inherent in Escherichia coli, is destroyed. On the other hand, it was confirmed that the purity decreased when genes encoding phosphofructokinase (pfkA and pfkB), which are similar glycolytic enzymes, were destroyed.
  • Example 4 ⁇ Isopropyl alcohol production from sucrose by Escherichia coli pGAP-Ia-cscA / GAPpatD genome insertion strain pgi disruption strain using 3L culture tank> (Replacement of the atoD promoter with the GAPDH promoter on the Escherichia coli B strain genome)
  • the entire nucleotide sequence of the genomic DNA of Escherichia coli MG1655 strain is known (GenBank accession number U00096), and the gene encoding the CoA transferase ⁇ subunit of Escherichia coli MG1655 strain (hereinafter sometimes abbreviated as atoD) Base sequences have also been reported. In other words, atoD is described in 23221469 to 2322131 of the Escherichia coli MG1655 strain genome sequence described in GenBank accession number U00096.
  • GAPDH glyceraldehyde 3-phosphate dehydrogenase
  • the genomic DNA of Escherichia coli MG1655 strain was used as a template, and cgctcaattgcaatgattgaacacgattccg (SEQ ID NO: 27) and agagaattcgctattttgttgtgattagatag (SEQ ID NO: 28) were obtained by the PCR method.
  • a DNA fragment encoding the GAPDH promoter of about 100 bp was obtained by digestion with EcoRI.
  • the resulting DNA fragment was mixed with plasmid pUC19 (GenBank accession number X02514) digested with restriction enzyme EcoRI and further treated with alkaline phosphatase, and ligase was used for binding, followed by Escherichia coli DH5 ⁇ strain competent cell ( Toyobo Co., Ltd. DNA-903) was transformed to obtain a transformant that grew on an LB agar plate containing 50 ⁇ g / mL of ampicillin.
  • the genomic DNA of Escherichia coli MG1655 strain was used as a template to obtain cgaattcgctgggtggagaatatatgaaaaaaaatgacattatacaagac (SEQ ID NO: 29), and the gcggtactttttttgtctctgtgtggt restriction DNA PCR Digestion with EcoRI and KpnI yielded an approximately 690 bp atoD fragment.
  • This DNA fragment was mixed with pUCgapP previously digested with restriction enzymes EcoRI and KpnI, ligated with ligase, transformed into Escherichia coli DH5 ⁇ strain competent cell (Toyobo Co., Ltd. DNA-903), and ampicillin. A transformant that grew on an LB agar plate containing 50 ⁇ g / mL was obtained. A plasmid was recovered from the obtained bacterial cells, and it was confirmed that atoD was correctly inserted. This plasmid was named pGAPatoD. Escherichia coli MG1655 strain can be obtained from the American Type Culture Collection.
  • ggtctagagcaatgattagaacgagtccgg (SEQ ID NO: 33) prepared based on the sequence information of the GAPDH promoter of Escherichia coli MG1655 strain and a primer of SEQ ID NO: 30 prepared based on the sequence information of atoD of Escherichia coli MG1655 strain.
  • PCR was performed using the expression vector pGAPatoD prepared earlier as a template to obtain a DNA fragment of about 790 bp consisting of the GAPDH promoter and atoD.
  • the fragments obtained above were digested with restriction enzymes PstI and XbaI, XbaI and KpnI, respectively, and this fragment was temperature-sensitive plasmid pTH18cs1 (GenBank accession number AB019610) [Hashimoto-Gotoh, T., Gene, 241, 185-191 (2000)] was mixed with a fragment obtained by digesting with PstI and KpnI, ligated with ligase, transformed into DH5 ⁇ strain, and applied to an LB agar plate containing 10 ⁇ g / ml of chloramphenicol at 30 ° C. A growing transformant was obtained. The obtained colony was cultured overnight at 30 ° C.
  • the primer of SEQ ID NO: 1 has an EcoRI recognition site on the 5 ′ end side
  • the primers of SEQ ID NOS: 2 and 3 have an XbaI recognition site on the 5 ′ end side
  • the primer of SEQ ID NO: 4 has a PstI recognition site on the 5 ′ end side, respectively.
  • a genomic DNA of Escherichia coli MG1655 strain was prepared, and the obtained genomic DNA was used as a template, and a DNA fragment of about 1.0 kb was amplified by PCR using the primer pair of SEQ ID NO: 34 and SEQ ID NO: 35. (Hereinafter sometimes referred to as a pgi-L fragment). In addition, a DNA fragment of about 1.0 kb was amplified by PCR using the primer pair of SEQ ID NO: 36 and SEQ ID NO: 37 (hereinafter sometimes referred to as pgi-R fragment).
  • DNA fragments were separated and collected by agarose electrophoresis, and the pgi-L fragment was digested with EcoRI and XbaI, and the pgi-R fragment was digested with XbaI and PstI, respectively.
  • the two digested fragments were mixed with EcoRI and PstI digests of temperature sensitive plasmid pTH18cs1 (GenBank accession number AB019610), reacted with T4 DNA ligase, and transformed into Escherichia coli DH5 ⁇ competent cell (manufactured by Toyobo Co., Ltd.).
  • a transformant was obtained that grew on an LB agar plate containing 10 ⁇ g / ml of chloramphenicol at 30 ° C.
  • a plasmid was recovered from the obtained transformant, and it was confirmed that two fragments, a 5 ′ upstream vicinity fragment and a 3 ′ downstream vicinity fragment of the gene encoding pgi were correctly inserted into pTH18cs1.
  • the obtained plasmid was digested with XbaI, and then blunt-ended with T4 DNA polymerase.
  • This DNA fragment and the pUC4K plasmid (GenBank accession number X06404) (Pharmacia) digested with EcoRI were ligated with T4 DNA ligase using a T4 DNA ligase.
  • the cells were transformed into Escherichia coli DH5 ⁇ competent cells to obtain transformants that grew at 30 ° C. on LB agar plates containing 10 ⁇ g / ml chloramphenicol and 50 ⁇ g / ml kanamycin.
  • the plasmid was recovered from the obtained transformant, and it was confirmed that the kanamycin somatic gene was correctly inserted between the 5 'upstream vicinity fragment and the 3' downstream vicinity fragment of the gene encoding pgi.
  • the plasmid thus obtained was transformed into the aforementioned Escherichia coli B strain atoD-deleted GAPpatoD genome insertion strain and cultured overnight at 30 ° C. on an LB agar plate containing 10 ⁇ g / ml of chloramphenicol and 50 ⁇ g / ml of kanamycin.
  • a transformant was obtained.
  • the obtained transformant was inoculated into an LB liquid medium containing kanamycin 50 ⁇ g / ml and cultured at 30 ° C. overnight. Next, a part of this culture solution was applied to an LB agar plate containing kanamycin 50 ⁇ g / ml to obtain colonies that grew at 42 ° C.
  • the obtained colonies were cultured in an LB liquid medium containing 50 ⁇ g / ml of kanamycin for 24 hours at 30 ° C., and further applied to an LB agar plate containing 50 ⁇ g / ml of kanamycin to obtain colonies that grew at 42 ° C.
  • a strain capable of amplification of about 3.3 kbp fragment by selection is selected, and the obtained strain is a GAPpatD genome insertion strain pgi gene deletion strain (hereinafter sometimes abbreviated as GAPpatoD genome insertion ⁇ pgi strain).
  • GAPpatoD genome insertion ⁇ pgi strain a GAPpatD genome insertion strain pgi gene deletion strain
  • Escherichia coli MG1655 strain can be obtained from the American Type Culture Collection.
  • Clostridium bacteria-derived acetoacetate decarboxylase gene Clostridium bacteria-derived isopropyl alcohol dehydrogenase gene, Escherichia coli O157-derived invertase gene expression vector, and construction of the expression vector transformant
  • Clostridial bacteria acetoacetate decarboxylase is described in GenBank accession number M55392, and isopropyl alcohol dehydrogenase is described in GenBank accession number AF157307.
  • isopropyl alcohol dehydrogenase gene Clostridium beijerinckii NRRL B-593 genomic DNA was used as a template.
  • the fragment was digested with restriction enzymes SphI and BamHI to obtain an isopropyl alcohol dehydrogenase fragment of about 1.1 kbp.
  • the obtained DNA fragment and the previously prepared plasmid pBRgapP were digested with restriction enzymes SphI and BamHI, mixed together using ligase, and then Escherichia coli DH5 ⁇ strain competent cell (Toyobo Co., Ltd.) Company DNA-903) was transformed to obtain transformants that grew on LB agar plates containing 50 ⁇ g / mL of ampicillin.
  • the obtained colony was cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid was recovered from the obtained bacterial cells to confirm that IPAdh was correctly inserted. It was named IPAdh.
  • Clostridium acetobutyricum ATCC824 genomic DNA was used as a template, and the DNA was obtained by using the gaggatccgctggtggaatatatgttaatagatatagatatac and g Digestion with restriction enzymes BamHI and EcoRI gave an acetoacetate decarboxylase fragment of about 700 bp.
  • the obtained DNA fragment and the previously prepared plasmid pGAP-IPAdh were digested with restriction enzymes BamHI and EcoRI, mixed together using ligase, and then Escherichia coli DH5 ⁇ strain competent cell (Toyo Spinning Co., Ltd.
  • DNA-903 was transformed to obtain a transformant that grew on an LB agar plate containing 50 ⁇ g / mL of ampicillin.
  • the obtained colonies were cultured overnight at 37 ° C. in an LB liquid medium containing 50 ⁇ g / mL of ampicillin, and the plasmid was recovered from the obtained bacterial cells to confirm that adc was correctly inserted.
  • -It was named Ia.
  • cscA The entire base sequence of the genomic DNA of Escherichia coli O157 strain is known (GenBank accession number AE005174), and the base sequence of a gene encoding the invertase of Escherichia coli O157 strain (hereinafter sometimes abbreviated as cscA) is also reported. Has been. That is, cscA is described in 3274383 to 3275816 of the Escherichia coli O157 strain genome sequence described in GenBankBaccession number AE005174.
  • cscA Escherichia coli O157 strain genomic DNA was used as a template for atgggtaccgctggtggaacatatgacccaatctcgattgcatg (SEQ ID NO: 42) and cgaattcttaaccccagtgtcccagagtgc (SEQ ID NO: 43). And digested with EcoRI, a cscA fragment of about 1470 bp was obtained.
  • This DNA fragment was mixed with the aforementioned pGAP-Ia (Clostridial bacteria-derived acetoacetate decarboxylase gene, Clostridium bacteria-derived isopropyl alcohol dehydrogenase gene expression vector) digested with restriction enzymes KpnI and EcoRI, and ligase was used. After binding, Escherichia coli DH5 ⁇ strain competent cells (Toyobo Co., Ltd., DNA-903) were transformed to obtain transformants that grew on LB agar plates containing 50 ⁇ g / mL ampicillin. A plasmid was recovered from the obtained cells, and it was confirmed that cscA was correctly inserted. This plasmid was named pGAP-Ia-cscA.
  • Isopropyl alcohol was produced in the same manner as in Example 3.
  • a sugar source 50% (w / w) sucrose was used instead of glucose.
  • the cell culture solution was sampled 120 hours after the start of the culture, and after removing the cells by centrifugation, the amount of product accumulated in the obtained culture supernatant was measured by HPLC according to a standard method.
  • a measured value is a total value in the culture solution after culture
  • Table 3 shows the concentration of the product after culturing and the purity of isopropyl alcohol.
  • isopropyl alcohol-producing Escherichia coli further having a sucrose hydrolase gene can destroy the gene (pgi) encoding glucose-6-phosphate isomerase that E. coli originally has even when sucrose is used as a raw material.
  • the gene (pgi) encoding glucose-6-phosphate isomerase that E. coli originally has even when sucrose is used as a raw material.
  • an isopropyl alcohol-producing Escherichia coli and an isopropyl alcohol production method useful for producing isopropyl alcohol with high purity can be provided.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La souche d'Escherichia coli productrice d'alcool isopropylique ci-décrite renferme un système de production d'alcool isopropylique, tout en étant inactivée du point de vue de l'activité glucose-6-phosphate isomérase. Un procédé de production d'alcool isopropylique à partir d'un matériau d'origine végétale utilisant la souche d'Escherichia coli productrice d'alcool isopropylique selon l'invention est également décrit.
PCT/JP2010/068631 2009-10-29 2010-10-21 Bactérie productrice d'alcool isopropylique et procédé de production d'alcool isopropylique WO2011052482A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011538386A JPWO2011052482A1 (ja) 2009-10-29 2010-10-21 イソプロピルアルコール生産細菌及びイソプロピルアルコール生産方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009-249418 2009-10-29
JP2009249418 2009-10-29

Publications (1)

Publication Number Publication Date
WO2011052482A1 true WO2011052482A1 (fr) 2011-05-05

Family

ID=43921905

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2010/068631 WO2011052482A1 (fr) 2009-10-29 2010-10-21 Bactérie productrice d'alcool isopropylique et procédé de production d'alcool isopropylique

Country Status (3)

Country Link
JP (1) JPWO2011052482A1 (fr)
TW (1) TW201124537A (fr)
WO (1) WO2011052482A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013022070A1 (fr) * 2011-08-11 2013-02-14 三井化学株式会社 Procédé pour produire de l'alcool isopropylique par culture continue
CN110462041A (zh) * 2017-03-27 2019-11-15 学校法人新潟科学技术学园 突变型2-脱氧-青蟹肌糖合酶

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001346578A (ja) * 2000-04-26 2001-12-18 Ajinomoto Co Inc アミノ酸生産菌及びアミノ酸の製造法
WO2007041269A2 (fr) * 2005-09-29 2007-04-12 E. I. Du Pont De Nemours And Company Production par fermentation de quatre alcools carbonés
JP2007510411A (ja) * 2003-11-06 2007-04-26 メタボリック エクスプローラ Ｎａｄｐｈ消費生合成経路のために最適化された微生物菌株
WO2009008377A1 (fr) * 2007-07-11 2009-01-15 Mitsui Chemicals, Inc. Bactérie de production d'alcool isopropylique et procédé de production d'alcool isopropylique à l'aide de cette bactérie

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001346578A (ja) * 2000-04-26 2001-12-18 Ajinomoto Co Inc アミノ酸生産菌及びアミノ酸の製造法
JP2007510411A (ja) * 2003-11-06 2007-04-26 メタボリック エクスプローラ Ｎａｄｐｈ消費生合成経路のために最適化された微生物菌株
WO2007041269A2 (fr) * 2005-09-29 2007-04-12 E. I. Du Pont De Nemours And Company Production par fermentation de quatre alcools carbonés
WO2009008377A1 (fr) * 2007-07-11 2009-01-15 Mitsui Chemicals, Inc. Bactérie de production d'alcool isopropylique et procédé de production d'alcool isopropylique à l'aide de cette bactérie

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HANAI T. ET AL.: "Engineered synthetic pathway for isopropanol production in esherichia coli.", APPL. ENVIRON. MICROB., vol. 73, no. 24, 2007, pages 7814 - 7818 *
JOJIMA T. ET AL.: "Production of isopropanol by metabolically engineered Escherichia coli.", APPL. MICROBIOL. BIOTECHNOL., vol. 77, 2008, pages 1219 - 1224, XP019586231, DOI: doi:10.1007/s00253-007-1246-8 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013022070A1 (fr) * 2011-08-11 2013-02-14 三井化学株式会社 Procédé pour produire de l'alcool isopropylique par culture continue
JPWO2013022070A1 (ja) * 2011-08-11 2015-03-05 三井化学株式会社 連続培養によるイソプロピルアルコール製造方法
US9150885B2 (en) 2011-08-11 2015-10-06 Mitsui Chemicals, Inc. Method for producing isopropyl alcohol by continuous culture
CN110462041A (zh) * 2017-03-27 2019-11-15 学校法人新潟科学技术学园 突变型2-脱氧-青蟹肌糖合酶
CN110462041B (zh) * 2017-03-27 2023-09-19 学校法人新潟科学技术学园 突变型2-脱氧-青蟹肌糖合酶

Also Published As

Publication number Publication date
TW201124537A (en) 2011-07-16
JPWO2011052482A1 (ja) 2013-03-21

Similar Documents

Publication Publication Date Title
US9150868B2 (en) Bacterium producing 2-deoxy-scyllo-inosose (DOI) and method of producing 2-deoxy-scyllo-inosose (DOI) by using same
TWI486453B (zh) 乳酸生產細菌及乳酸生產方法
WO2012020833A1 (fr) Bactérie produisant de l'alcool isopropylique présentant une productivité améliorée par destruction de gntr
JP5243546B2 (ja) 植物由来原料から乳酸を生産する方法及び乳酸生産細菌
KR101521045B1 (ko) 유기산을 생산하기 위한 재조합 미생물유기체
JPWO2010032698A6 (ja) 植物由来原料から乳酸を生産する方法及び乳酸生産細菌
JP5628288B2 (ja) 生産性の高いイソプロピルアルコール生産細菌
WO2011052482A1 (fr) Bactérie productrice d'alcool isopropylique et procédé de production d'alcool isopropylique
JP5568562B2 (ja) イソプロピルアルコール生産細菌及びイソプロピルアルコール生産方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10826614

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2011538386

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10826614

Country of ref document: EP

Kind code of ref document: A1